• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » LifeScience Alley to rebrand as Medical Alley Association

LifeScience Alley to rebrand as Medical Alley Association

January 6, 2016
CenterWatch Staff

LifeScience Alley, a Minneapolis-based trade organization, will be rebranded as the Medical Alley Association, reconnecting with its historic link to the Minnesota health technology industry which includes: medical device, biopharmaceutical, diagnostics and digital health sectors.

For more than three decades, the organization has represented Minnesota’s innovative healthcare companies helping to build global recognition of the region known as Medical Alley.

The transformed Medical Alley Association provides members with advocacy at the local and national levels, original research and critical insights, connections to professional peers, relevant training resources and events. As part of the brand introduction, a new website and brand identity will be launched in January highlighting the vision for the Medical Alley Association serving as a primary content provider; a hub of a global health technology cluster. The relaunch provides a platform to refocus its efforts to better serve the community that is essential to Minnesota’s thriving healthcare environment.

“The Medical Alley Association is committed to elevating the region as a global epicenter of health innovation,” said Shaye Mandle, CEO and president of the Medical Alley Association. “Our role and goal is to influence relevant policy, foster connections and deliver the insights needed to improve access to new therapies for patients in need around the world.”

“The Medical Alley Association rebrand carries forward our historical spirit of rich innovation and unparalleled support for our constituents. It also allows us to focus our efforts in strengthening our leadership role in advocacy, research, and enhancing connectivity among industry stakeholders,” said Dr. Rob Kieval, board chair of the Medical Alley Association.

The Medical Alley Association collaborated with two local agencies to bring the rebrand to life: StoneArch and Risdall Public Relations. StoneArch developed the brand identity and Risdall Public Relations designed the media launch strategy. Both creative organizations have served Medical Alley’s largest organizations for more than 30 years and were uniquely positioned as they also are lifetime Medical Alley Association members.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing